NCT02918409View on ClinicalTrials.gov

IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy

PHASE4CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

August 26, 2016

Primary Completion Date

September 10, 2020

Study Completion Date

November 22, 2021

Conditions
Cystic Fibrosis
Interventions
DRUG

Colistin

DRUG

Tobramycin

Trial Locations (1)

80206

National Jewish Health, Denver

All Listed Sponsors
lead

National Jewish Health

OTHER

NCT02918409 - IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy | Biotech Hunter | Biotech Hunter